BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35151105)

  • 21. Cerebrospinal fluid cytokines in metastatic group 3 and 4 medulloblastoma.
    Low SYY; Bte Syed Sulaiman N; Tan EEK; Ng LP; Kuick CH; Chang KTE; Tang PH; Wong RX; Looi WS; Low DCY; Seow WT
    BMC Cancer; 2020 Jun; 20(1):554. PubMed ID: 32539808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Young investigator challenge: Cytomorphologic analysis of cerebrospinal fluid in 70 pediatric patients with medulloblastoma and review of the literature focusing on novel diagnostic and prognostic tests.
    Damiani D; Suciu V; Andreiuolo F; Calderaro J; Vielh P
    Cancer Cytopathol; 2015 Nov; 123(11):644-9. PubMed ID: 26769585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medulloblastoma: staging and treatment outcome.
    Deutsch M
    Int J Radiat Oncol Biol Phys; 1988 Jun; 14(6):1103-7. PubMed ID: 3384715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors for medulloblastoma.
    Jenkin D; Shabanah MA; Shail EA; Gray A; Hassounah M; Khafaga Y; Kofide A; Mustafa M; Schultz H
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):573-84. PubMed ID: 10837938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: a prospective observational multicentre study.
    Friedrich C; von Bueren AO; von Hoff K; Kwiecien R; Pietsch T; Warmuth-Metz M; Hau P; Deinlein F; Kuehl J; Kortmann RD; Rutkowski S
    Eur J Cancer; 2013 Mar; 49(4):893-903. PubMed ID: 23182688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Newly Diagnosed Metastatic Intracranial Ependymoma in Children: Frequency, Molecular Characteristics, Treatment, and Outcome in the Prospective HIT Series.
    Benesch M; Mynarek M; Witt H; Warmuth-Metz M; Pietsch T; Bison B; Pfister SM; Pajtler KW; Kool M; Schüller U; Pietschmann K; Juhnke BO; Tippelt S; Fleischhack G; Schmid I; Kramm CM; Vorwerk P; Beilken A; Classen CF; Hernáiz Driever P; Kropshofer G; Imschweiler T; Lemmer A; Kortmann RD; Rutkowski S; von Hoff K
    Oncologist; 2019 Sep; 24(9):e921-e929. PubMed ID: 30850560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The treatment of adults with medulloblastoma: a prospective study.
    Brandes AA; Ermani M; Amista P; Basso U; Vastola F; Gardiman M; Iuzzolino P; Turazzi S; Rotilio A; Volpin L; Mazza C; Sainati L; Ammannati F; Berti F
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):755-61. PubMed ID: 14529781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microscopic local leptomeningeal invasion at diagnosis of medulloblastoma.
    Ayan I; Kebudi R; Bayindir C; Darendeliler E
    Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):461-6. PubMed ID: 9308951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival and prognostic factors in a series of adults with medulloblastomas.
    Riffaud L; Saikali S; Leray E; Hamlat A; Haegelen C; Vauleon E; Lesimple T
    J Neurosurg; 2009 Sep; 111(3):478-87. PubMed ID: 19231932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management and treatment of children with medulloblastoma in Serbia, a middle-income country.
    Bokun J; Grujicic D; Skender-Gazibara M; Paripovic L; Pekmezovic T; Kisic-Tepavcevic D; Ilic V; Raicevic S; Stanic D; Miskovic I; Saric M; Nikitovic M
    J BUON; 2018; 23(4):1156-1162. PubMed ID: 30358225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of lumbar and shunt cerebrospinal fluid specimens for cytologic detection of leptomeningeal disease in pediatric patients with brain tumors.
    Gajjar A; Fouladi M; Walter AW; Thompson SJ; Reardon DA; Merchant TE; Jenkins JJ; Liu A; Boyett JM; Kun LE; Heideman RL
    J Clin Oncol; 1999 Jun; 17(6):1825-8. PubMed ID: 10561221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study.
    Schwalbe EC; Lindsey JC; Nakjang S; Crosier S; Smith AJ; Hicks D; Rafiee G; Hill RM; Iliasova A; Stone T; Pizer B; Michalski A; Joshi A; Wharton SB; Jacques TS; Bailey S; Williamson D; Clifford SC
    Lancet Oncol; 2017 Jul; 18(7):958-971. PubMed ID: 28545823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneous seeding of medulloblastoma: results of cerebrospinal fluid cytology and arachnoid biopsy from the cisterna magna.
    Tomita T; McLone DG
    Neurosurgery; 1983 Mar; 12(3):265-7. PubMed ID: 6843796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of concurrent carboplatin during full-dose craniospinal irradiation for high-risk/metastatic medulloblastoma in a resource-limited setting.
    Gupta T; Sinha S; Chinnaswamy G; Vora T; Prasad M; Bhat V; Goda JS; Krishnatry R; Chatterjee A; Epari S; Sahay A; Moiyadi A; Shetty P; Patil V; Khatua S; Jalali R; Kurkure P
    Pediatr Blood Cancer; 2021 May; 68(5):e28925. PubMed ID: 33533557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategy to minimize radiation burden in infants and high-risk medulloblastoma using intrathecal methotrexate and high-dose chemotherapy: A prospective registry study in Japan.
    Yamasaki K; Okada K; Soejima T; Sakamoto H; Hara J
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28012. PubMed ID: 31544362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison between cytospin and liquid-based cytology in cerebrospinal fluid diagnosis of neoplastic diseases: A single institution experience.
    Straccia P; Fadda G; Pierconti F
    Cytopathology; 2019 Mar; 30(2):236-240. PubMed ID: 30468697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic relevance of clinical and molecular risk factors in children with high-risk medulloblastoma treated in the phase II trial PNET HR+5.
    Dufour C; Foulon S; Geoffray A; Masliah-Planchon J; Figarella-Branger D; Bernier-Chastagner V; Padovani L; Guerrini-Rousseau L; Faure-Conter C; Icher C; Bertozzi AI; Leblond P; Akbaraly T; Bourdeaut F; André N; Chappé C; Schneider P; De Carli E; Chastagner P; Berger C; Lejeune J; Soler C; Entz-Werlé N; Delisle MB
    Neuro Oncol; 2021 Jul; 23(7):1163-1172. PubMed ID: 33377141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myelography and cytology for staging very young children with medulloblastoma.
    Deutsch M
    Am J Clin Oncol; 1983 Dec; 6(6):657-60. PubMed ID: 6637878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exclusive Hyperfractionated Radiation Therapy and Reduced Boost Volume for Standard-Risk Medulloblastoma: Pooled Analysis of the 2 French Multicentric Studies MSFOP98 and MSFOP 2007 and Correlation With Molecular Subgroups.
    Carrie C; Kieffer V; Figarella-Branger D; Masliah-Planchon J; Bolle S; Bernier V; Laprie A; Supiot S; Leseur J; Habrand JL; Alapetite C; Kerr C; Dufour C; Claude L; Chapet S; Huchet A; Bondiau PY; Escande A; Truc G; Nguyen TD; Pasteuris C; Vigneron C; Muracciole X; Bourdeaut F; Appay R; Dubray B; Colin C; Ferlay C; Dussart S; Chabaud S; Padovani L; ;
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1204-1217. PubMed ID: 32768563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebrospinal fluid cytology: an 11-year experience with 5951 specimens.
    Prayson RA; Fischler DF
    Arch Pathol Lab Med; 1998 Jan; 122(1):47-51. PubMed ID: 9448016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.